Study S002561

Whole Gut Motility Abnormalities Following GLP-1 Receptor Agonist (GLP-1RA) Initiation

Name: LivingGLP1 adjudicated trial data and network meta-analysis results
Creator: Ahmad Sofi-Mahmudi
License: https://creativecommons.org/licenses/by/4.0/

ClinicalTrials.gov record

Registration

Registration: NCT07784127
Study type: INTERVENTIONAL
Masking: NONE
Status: NOT_YET_RECRUITING
Enrollment: 20
Start: 2026-12
Primary completion: 2028-08
Lead sponsor: The Cleveland Clinic
Conditions: Diabetes
Interventions: PROCEDURE:Gut motility quantification using a capsule after initiating GLP-1RA therapy
Results posted: FALSE
Individual participant data sharing: UNDECIDED

Registered primary outcomes

Patient reported outcome for gastroparesis symptoms as assessed by Gastroparesis Cardinal Symptom Index (GCSI) Questionnaire [At Baseline and 3 Month Follow Up]
Patient-Reported Severity and Frequency of Gastrointestinal Symptoms as Assessed by Gastrointestinal Symptom Rating Scale (GSRS) Questionnaire [At Baseline and 3 Month Follow Up]
Patient-Reported frequency, duration, and diagnostic criteria for conditions affecting the gastrointestinal tract for colonic motility and function as Assessed by Rome IV Diagnostic Questionnaire [At Baseline and 3 Month Follow Up]

Linked records (0)

Automatic links, confirmed or rejected during screening. A record citing this registration may be a secondary analysis, a commentary or a review that mentions the trial.

No records link to this registration yet.